Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Nutranomics, Inc.
DRAPER, Utah, Nov. 4, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to report that the Company has received a repeat purchase order from Shirlyn's Natural Foods Inc., a full-service boutique health food store chain catering to the Salt Lake City area.
Carollee Darger, co-owner of Shirlyn's Natural Foods, "We are proud to carry the Nutranomics line of whole food supplements in all our stores. The Nutranomics Total System Enzyme is still one of our bestselling enzyme products and has many customers coming back for more."
"Nutranomics currently sells its line of high quality health food supplement products under its own brand to roughly 80 select retail outlets across the USA," explained Michael J. Brousseau, new General Manager of Nutranomics. "Up until recently, R&D and private label product development had been our primary focus and we hadn't dedicated much of our energy towards building our own retail distribution. However, our products have still earned an extremely loyal retail following that we intend to build upon with the launch of a new strategy and campaign in Spring 2014 to further expand the Nutranomics brand into more retail outlets in the USA and possibly other countries as well."
According to Natural Foods Investor Newsletter, "There has never been a better time to invest in the expanding natural products industry. Including sales of natural products across all retail and direct-to-consumer channels, this $62 billion dollar industry has almost doubled in size from $32 billion in 2001. Because of the fact that Americans now are becoming more and more health conscious, especially due to scientific research proving that chemicals in food are the cause of many diseases, natural health foods, like organic raw food and organic health food, have become a driving force for the industry."
Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia.
For further information regarding Nutranomics, Inc., please contact our investor relations representatives at email@example.com or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include the Company's plan to execute and accelerate its global sales and marketing plans. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
©2012 PR Newswire. All Rights Reserved.